{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:54:15Z","timestamp":1791334455003,"version":"4.3.1"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsurgicalresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jss.2026.06.060","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:40:00Z","timestamp":1784594400000},"page":"408-412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Adoption of Adjuvant Immunotherapy for Stage IIB\/C Head and Neck Versus Nonhead and Neck Melanoma"],"prefix":"10.1016","volume":"326","author":[{"given":"Kyle","family":"Polen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5963-4513","authenticated-orcid":false,"given":"Gracia Maria","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis-Xavier","family":"Barrette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Saad","family":"Farooq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell A.","family":"Simons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Brody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgos C.","family":"Karakousis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2026.06.060_bib1","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1001\/jamaoto.2023.0076","article-title":"Association of complex lymphatic drainage in head and neck cutaneous melanoma with sentinel lymph node biopsy outcomes: a cohort study and literature review","volume":"149","author":"Pasha","year":"2023","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jss.2026.06.060_bib2","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1177\/01945998211053204","article-title":"The national cancer database: survival between head and neck melanoma and melanoma of other regions","volume":"167","author":"Cabrera","year":"2022","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jss.2026.06.060_bib3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jaad.2024.06.107","article-title":"Comparison of clinicopathological features and treatment outcomes for cutaneous melanomas of the head and neck and melanomas arising at other sites: implications for systemic therapy","volume":"92","author":"Li","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jss.2026.06.060_bib4","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.suc.2024.11.003","article-title":"Special considerations for head and neck melanoma","volume":"105","author":"Scott","year":"2025","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.jss.2026.06.060_bib5","doi-asserted-by":"crossref","first-page":"8456","DOI":"10.1245\/s10434-022-12364-9","article-title":"National practice patterns in the management of the regional lymph node basin after positive sentinel lymph node biopsy for cutaneous melanoma","volume":"29","author":"Sharon","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2026.06.060_bib6","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.1200\/JCO.23.01136","article-title":"Systemic therapy for melanoma: ASCO guideline update","volume":"41","author":"Seth","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2026.06.060_bib7","series-title":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) for Melanoma: Cutaneous V.2.2024","year":"2024"},{"key":"10.1016\/j.jss.2026.06.060_bib8","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.2217\/fon-2019-0666","article-title":"KEYNOTE-716: phase III study of adjuvant pembrolizumab versus placebo in resected high-risk stage II melanoma","volume":"16","author":"Luke","year":"2020","journal-title":"Future Oncol"},{"key":"10.1016\/j.jss.2026.06.060_bib9","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1038\/s41591-023-02583-2","article-title":"Adjuvant nivolumab in resected stage IIB\/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial","volume":"29","author":"Kirkwood","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.jss.2026.06.060_bib10","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1002\/lary.32269","article-title":"Survival correlates with adjuvant choice in sentinel node positive head and neck cutaneous melanoma","volume":"135","author":"Dadafarin","year":"2025","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jss.2026.06.060_bib11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00262-024-03750-1","article-title":"Efficacy of adjuvant immune checkpoint inhibitors pembrolizumab or nivolumab in melanoma patients >\/= 75 years: results of a real-world cohort including 456 patients","volume":"73","author":"Gawaz","year":"2024","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jss.2026.06.060_bib12","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1002\/cncr.34230","article-title":"Frailty and checkpoint inhibitor toxicity in older patients with melanoma","volume":"128","author":"Bruijnen","year":"2022","journal-title":"Cancer"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480426004476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480426004476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:47:45Z","timestamp":1791334065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480426004476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":12,"alternative-id":["S0022480426004476"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2026.06.060","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adoption of Adjuvant Immunotherapy for Stage IIB\/C Head and Neck Versus Nonhead and Neck Melanoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2026.06.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}